HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Staib, C. Articles by Sutter, G. Search for Related Content PubMed PubMed Citation Articles by Staib, C. Articles by Sutter, G. Agricola Articles by Staib, C. Articles by Sutter, G.

Short-term, but not post-exposure, protection against lethal orthopoxvirus challenge after immunization with modified vaccinia virus Ankara

Yasemin Suezer^2,

Sigrid Kisling^1,

¹ GSF – Institute of Molecular Virology and Institute of Virology, Technical University of Munich, 81675 München, Germany
² Paul-Ehrlich-Institut, Paul-Ehrlich-Straße 51–59, 63225 Langen, Germany

Correspondence
Gerd Sutter
sutge{at}pei.de

Safety-tested vaccinia virus (VACV) MVA serves as a candidate third-generation vaccine against smallpox. Here, MVA immunization of mice shortly before or after lethal respiratory challenge with VACV Western Reserve was investigated. Whilst post-exposure treatment failed to protect animals, immunizations on day 2 prior to challenge were fully protective. On the day of challenge, MVA inoculation may prevent death, but not onset of severe respiratory disease. After intranasal MVA application, massive influx of leukocytes (such as neutrophils, macrophages, natural killer cells and T cells) was found in the lungs of the animals, indicating the contribution of innate responses to protection. Correspondingly, in RAG-1^–/– mice, MVA inoculation delayed onset of disease significantly, but did not prevent fatal infection. Thus, short-term protection required a tight interplay of both innate and adaptive antiviral immunity. These data suggest that, in addition to conventional vaccination, MVA may serve for potent emergency prophylaxis against orthopoxvirus infection.

These authors contributed equally to this work.

This article has been cited by other articles:

				M. H. Lehmann, W. Kastenmuller, J. D. Kandemir, F. Brandt, Y. Suezer, and G. Sutter Modified Vaccinia Virus Ankara Triggers Chemotaxis of Monocytes and Early Respiratory Immigration of Leukocytes by Induction of CCL2 Expression J. Virol., March 15, 2009; 83(6): 2540 - 2552. [Abstract] [Full Text] [PDF]

				P. L. Earl, J. L. Americo, L. S. Wyatt, O. Espenshade, J. Bassler, K. Gong, S. Lin, E. Peters, L. Rhodes Jr, Y. E. Spano, et al. Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus PNAS, August 5, 2008; 105(31): 10889 - 10894. [Abstract] [Full Text] [PDF]